{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:13:31Z","timestamp":1767374011061,"version":"build-2065373602"},"reference-count":12,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The advances in the field of gene therapy have significantly improved the possibility for nucleic acids as highly promising agents for the treatment of both inherited and acquired human diseases [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics13040446","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:17:53Z","timestamp":1616764673000},"page":"446","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-Viral Gene Delivery Systems"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5554-7829","authenticated-orcid":false,"given":"Henrique","family":"Faneca","sequence":"first","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Guan, G., Song, B., Zhang, J., Chen, K., Hu, H., Wang, M., and Chen, D. (2019). An effective cationic human serum albumin-based gene delivery carrier containing nuclear localization signal. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11110608"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Negro, M., S\u00e1nchez-Arribas, N., Guerrero-Mart\u00ednez, A., Moy\u00e1, M.L., Ilarduya, C., Mendicuti, F., Aicart, E., and Junquera, E. (2019). A non-viral plasmid DNA delivery system consisting on a lysine-derived cationic lipid mixed with a fusogenic lipid. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120632"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Saher, O., Lehto, T., Gissberg, O., Gupta, D., Gustafsson, O., Andaloussi, S., Darbre, T., Lundin, K., Smith, E., and Zain, R. (2019). Sugar and polymer excipients enhance uptake and splice-switching activity of peptide-dendrimer\/lipid\/oligonucleotide formulations. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120666"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ibaraki, H., Kanazawa, T., Owada, M., Iwaya, K., Takashima, Y., and Seta, Y. (2020). Anti-Metastatic Effects on Melanoma via intravenous administration of anti-NF-\u03baB siRNA complexed with functional peptide-modified nano-micelles. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010064"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nagachinta, S., Bouzo, B.L., V\u00e1zquez-R\u00edos, A.J., Lopez, R., and de la Fuente, M. (2020). Sphingomyelin-Based Nanosystems (SNs) for the development of anticancer miRNA therapeutics. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020189"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Taylor, R.E., and Zahid, M. (2020). Cell penetrating peptides, novel vectors for gene therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030225"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Roma-Rodrigues, C., Rivas-Garc\u00eda, L., Baptista, P.V., and Fernandes, A.R. (2020). Gene therapy in cancer treatment: Why going nano?. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030233"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sato, M., Inada, M., Saitoh, I., Watanabe, S., and Nakamura, S. (2020). piggyBac-Based non-viral in vivo gene delivery useful for production of genetically modified animals and organs. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030277"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Carvalho, A.M., Cordeiro, R.A., and Faneca, H. (2020). Silica-based gene delivery systems: From design to therapeutic applications. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070649"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Carballo-Pedrares, N., Fuentes-Boquete, I., D\u00edaz-Prado, S., and Rey-Rico, A. (2020). Hydrogel-based localized nonviral gene delivery in regenerative medicine approaches\u2014An overview. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080752"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Aulicino, F., Capin, J., and Berger, I. (2020). Synthetic virus-derived nanosystems (SVNs) for delivery and precision docking of large multifunctional DNA circuitry in mammalian cells. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080759"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Egorova, A., Shtykalova, S., Selutin, A., Shved, N., Maretina, M., Selkov, S., Baranov, V., and Kiselev, A. (2021). Development of iRGD-modified peptide carriers for suicide gene therapy of uterine leiomyoma. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020202"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/4\/446\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:53:02Z","timestamp":1760363582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/4\/446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":12,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["pharmaceutics13040446"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13040446","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2021,3,26]]}}}